Image not available

Introducing...

xtalline

Image not available
Image not available

xtalline: Simple, low-cost and portable.

xtalline: Simple, low-cost and portable.
Move testing outside the laboratory.

xtalline: Fast, quantative and reliable.

xtalline: Fast, quantative and reliable.
For immediate and accurate decisions.

xtalline: Wireless connectivity.

xtalline: Wireless connectivity.
From sample to smartphone in seconds.

xtalline: Multiple, diverse applications.

xtalline: Multiple, diverse applications.
In hospitals…

xtalline: Multiple, diverse applications.
In hospitals, patients’ homes…

xtalline: Multiple, diverse applications.
In hospitals, patients’ homes, remote areas…

xtalline: Multiple, diverse applications.
In hospitals, patients’ homes, remote areas
and for veterinaries in the field.

xtalline: We welcome partnerships

xtalline: We welcome partnerships
to find new applications for our technology.

About OJ-Bio

OJ-Bio was a UK based joint venture company established in 2009 by Japan Radio Co., Ltd. (JRC), a Japanese wireless communication company and Orla Protein Technologies (ORLA) a UK-based unique protein company. OJ-Bio has developed a Surface Acoustic Wave (SAW) biosensor platform; we have named it “Xtalsens”. The development has reached a significant milestone and both companies, JRC and ORLA have agreed that the time is right to transfer all the activities to JRC.
At this moment, the mission of OJ-Bio has been completed, the joint venture company, OJ-Bio has been shut down and will officially be liquidated soon. On the other hand, the name of OJ-Bio is well known over the “bio” world through its excellent work for the past several years. JRC, therefore, wishes to keep the logo “OJ-Bio” and the website “OJ-Bio.com”. JRC will update current activities through the OJ-Bio website.
Xtalsens enables multiple bio tests and applications in one device. OJ-Bio’s lead application is a biochip that can measure the biomarker C-Reactive Protein (CRP), which allows determination of whether an infection is caused by bacteria and whether or not antibiotics are required. Additionally, products for other applications including periodontal disease, flu and HIV are in the pipeline. OJ-Bio welcomes partnerships to find new and additional applications for its technology to develop new products and discover new commercial opportunities.

×